These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1948130)

  • 41. Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma.
    Wadler S; Schwartz EL; Goldman M; Lyver A; Rader M; Zimmerman M; Itri L; Weinberg V; Wiernik PH
    J Clin Oncol; 1989 Dec; 7(12):1769-75. PubMed ID: 2585018
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multicenter randomized trial of dacarbazine alone or in combination with two different doses and schedules of interferon alfa-2a in the treatment of advanced melanoma.
    Bajetta E; Di Leo A; Zampino MG; Sertoli MR; Comella G; Barduagni M; Giannotti B; Queirolo P; Tribbia G; Bernengo MG
    J Clin Oncol; 1994 Apr; 12(4):806-11. PubMed ID: 8151323
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modification of the antitumor activity of chemotherapeutic drugs by the hypoxic cytotoxic agent tirapazamine.
    Dorie MJ; Brown JM
    Cancer Chemother Pharmacol; 1997; 39(4):361-6. PubMed ID: 9025778
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ciprofloxacin sensitizes hormone-refractory prostate cancer cell lines to doxorubicin and docetaxel treatment on a schedule-dependent manner.
    Pinto AC; Moreira JN; Simões S
    Cancer Chemother Pharmacol; 2009 Aug; 64(3):445-54. PubMed ID: 19104815
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interferon beta increases antitumor activity of 5-fluorouracil against human colon carcinoma cells in vitro and in vivo.
    Kase S; Kubota T; Watanabe M; Furukawa T; Tanino H; Ishibiki K; Teramoto T; Kitajima M
    Anticancer Res; 1993; 13(2):369-73. PubMed ID: 8517649
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phase I study of alpha 2-interferon plus doxorubicin in patients with solid tumors.
    Sarosy GA; Brown TD; Von Hoff DD; Spiegel RJ; Golando JP; Beougher KL; Kuhn JG; Kisner DL
    Cancer Res; 1986 Oct; 46(10):5368-71. PubMed ID: 3756887
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effect of combined treatment of Shuanghuanglian and recombinant interferon alpha 2a on coxsackievirus B3 replication in vitro].
    Lu HT; Yang JC; Yuan ZC; Sheng WH; Yan WH
    Zhongguo Zhong Yao Za Zhi; 2000 Nov; 25(11):682-4. PubMed ID: 12525074
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interferons alpha-2a and beta increase the antitumor activity, detected by MTT assay, of 5-fluorouracil against experimental and clinical human gastrointestinal carcinomas.
    Kubota T; Kase S; Otani Y; Watanabe M; Teramoto T; Kitajima M
    Anticancer Res; 1997; 17(1B):725-8. PubMed ID: 9066609
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The treatment of advanced gastric cancer.
    Wils J
    Semin Oncol; 1996 Jun; 23(3):397-406. PubMed ID: 8658224
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combinations of paclitaxel and etoposide in the treatment of lung cancer.
    Perez EA; Buckwalter CA; Reid JP
    Semin Oncol; 1996 Dec; 23(6 Suppl 15):21-5. PubMed ID: 8996593
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro studies on the influence of doxorubicin in combination with recombinant interferon-gamma on human monocytes.
    Van Schie RC; De Mulder PH; Verstraten HG; Van Rennes H; Wagener DJ
    Anticancer Res; 1991; 11(3):1245-52. PubMed ID: 1832272
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genes associated with human hepatocellular carcinoma cell chemosensitivity to 5-fluorouracil plus interferon-alpha combination chemotherapy.
    Moriyama M; Hoshida Y; Kato N; Otsuka M; Yoshida H; Kawabe T; Omata M
    Int J Oncol; 2004 Nov; 25(5):1279-87. PubMed ID: 15492816
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increasing the efficacy of 5-fluorouracil with interferons: preclinical, clinical, and pharmacokinetic studies.
    Sparano JA; Wadler S
    Adv Exp Med Biol; 1993; 339():125-31; discussion 165-7. PubMed ID: 8178711
    [No Abstract]   [Full Text] [Related]  

  • 54. In vitro testing of chemotherapeutic combinations in a rapid thymidine incorporation assay.
    Sondak VK; Korn EL; Kern DH
    Int J Cell Cloning; 1988 Nov; 6(6):378-91. PubMed ID: 3230328
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synergistic antitumour effect of a combination of toremifene and interferon-alpha on ZR-75-1 human breast cancer cells: dependence on interferon-alpha subtype.
    Martin JH; Symonds A
    Oncol Rep; 2002; 9(2):379-82. PubMed ID: 11836612
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PTK787/ZK222584 combined with interferon alpha and 5-fluorouracil synergistically inhibits VEGF signaling pathway in hepatocellular carcinoma.
    Katsura Y; Wada H; Murakami M; Akita H; Hama N; Kawamoto K; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Umeshita K; Doki Y; Mori M; Nagano H
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S517-26. PubMed ID: 23508585
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessing combinations of cytotoxic agents using leukemia cell lines.
    Reynolds CP; Kang MH; Keshelava N; Maurer BJ
    Curr Drug Targets; 2007 Jun; 8(6):765-71. PubMed ID: 17584032
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanisms by which interferon potentiates chemotherapy.
    Hoffman MA; Wadler S
    Cancer Invest; 1993; 11(3):310-3. PubMed ID: 8485653
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activity of human leukocyte interferon in a human tumor cloning system.
    Von Hoff DD; Gutterman J; Portnoy B; Coltman CA
    Cancer Chemother Pharmacol; 1982; 8(1):99-103. PubMed ID: 6178527
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modulation of chemotherapy antineoplastic agents with biologic agents: enhancement of antitumor activities by interleukin-1.
    Johnson CS
    Curr Opin Oncol; 1992 Dec; 4(6):1108-15. PubMed ID: 1457525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.